These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 30859853)

  • 1. By downregulating PBX3, miR-526b suppresses the epithelial-mesenchymal transition process in cervical cancer cells.
    Li H; Wang J; Xu F; Wang L; Sun G; Wang J; Yang Y
    Future Oncol; 2019 May; 15(14):1577-1591. PubMed ID: 30859853
    [No Abstract]   [Full Text] [Related]  

  • 2. MicroRNA-124 inhibits proliferation, invasion, migration and epithelial-mesenchymal transition of cervical carcinoma cells by targeting astrocyte-elevated gene-1.
    Zhang X; Cai D; Meng L; Wang B
    Oncol Rep; 2016 Oct; 36(4):2321-8. PubMed ID: 27571703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-211 inhibits invasion and epithelial-to-mesenchymal transition (EMT) of cervical cancer cells via targeting MUC4.
    Xu D; Liu S; Zhang L; Song L
    Biochem Biophys Res Commun; 2017 Apr; 485(2):556-562. PubMed ID: 27923652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-361-Mediated Inhibition of HSP90 Expression and EMT in Cervical Cancer Is Counteracted by Oncogenic lncRNA NEAT1.
    Xu D; Dong P; Xiong Y; Yue J; Konno Y; Ihira K; Kobayashi N; Todo Y; Watari H
    Cells; 2020 Mar; 9(3):. PubMed ID: 32151082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNA-145 modulates epithelial-mesenchymal transition and suppresses proliferation, migration and invasion by targeting SIP1 in human cervical cancer cells.
    Sathyanarayanan A; Chandrasekaran KS; Karunagaran D
    Cell Oncol (Dordr); 2017 Apr; 40(2):119-131. PubMed ID: 27933466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-218 inhibits EMT, migration and invasion by targeting SFMBT1 and DCUN1D1 in cervical cancer.
    Jiang Z; Song Q; Zeng R; Li J; Li J; Lin X; Chen X; Zhang J; Zheng Y
    Oncotarget; 2016 Jul; 7(29):45622-45636. PubMed ID: 27285984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in cervical cancer.
    Guo M; Zhao X; Yuan X; Jiang J; Li P
    Oncotarget; 2017 Apr; 8(17):28226-28236. PubMed ID: 28415668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-1297 inhibits metastasis and epithelial-mesenchymal transition by targeting AEG-1 in cervical cancer.
    Wang Z; He S; Guo P; Guo X; Zheng J
    Oncol Rep; 2017 Nov; 38(5):3121-3129. PubMed ID: 29048632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1.
    Deng S; Li X; Niu Y; Zhu S; Jin Y; Deng S; Chen J; Liu Y; He C; Yin T; Yang Z; Tao J; Xiong J; Wu H; Wang C; Zhao G
    Oncotarget; 2015 Nov; 6(37):39661-75. PubMed ID: 26498682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of MicroRNA-101 Promotes Epithelial to Mesenchymal Transition in Hepatocytes.
    Zhao S; Zhang Y; Zheng X; Tu X; Li H; Chen J; Zang Y; Zhang J
    J Cell Physiol; 2015 Nov; 230(11):2706-17. PubMed ID: 25808945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tripartite motif containing 62 is a novel prognostic marker and suppresses tumor metastasis via c-Jun/Slug signaling-mediated epithelial-mesenchymal transition in cervical cancer.
    Liu TY; Chen J; Shang CL; Shen HW; Huang JM; Liang YC; Wang W; Zhao YH; Liu D; Shu M; Guo LY; Hu Z; Yao SZ
    J Exp Clin Cancer Res; 2016 Oct; 35(1):170. PubMed ID: 27793172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-182 inhibits the epithelial to mesenchymal transition and metastasis of lung cancer cells by targeting the Met gene.
    Li Y; Zhang H; Li Y; Zhao C; Fan Y; Liu J; Li X; Liu H; Chen J
    Mol Carcinog; 2018 Jan; 57(1):125-136. PubMed ID: 28940757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-31 Functions as an Oncomir Which Promotes Epithelial-Mesenchymal Transition via Regulating BAP1 in Cervical Cancer.
    Wang N; Li Y; Zhou J
    Biomed Res Int; 2017; 2017():6361420. PubMed ID: 29159179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-144-3p suppresses gastric cancer progression by inhibiting epithelial-to-mesenchymal transition through targeting PBX3.
    Li B; Zhang S; Shen H; Li C
    Biochem Biophys Res Commun; 2017 Mar; 484(2):241-247. PubMed ID: 28111340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer.
    Xu Q; Sun Q; Zhang J; Yu J; Chen W; Zhang Z
    Carcinogenesis; 2013 Mar; 34(3):539-49. PubMed ID: 23188671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3.
    Fan Z; Cui H; Xu X; Lin Z; Zhang X; Kang L; Han B; Meng J; Yan Z; Yan X; Jiao S
    Oncotarget; 2015 Sep; 6(28):25266-80. PubMed ID: 26389681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-486 inhibited osteosarcoma cells invasion and epithelial-mesenchymal transition by targeting PIM1.
    Liu Y; Zhang J; Xing C; Wei S; Guo N; Wang Y
    Cancer Biomark; 2018; 23(2):269-277. PubMed ID: 30103304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-promoting properties of miR-8084 in breast cancer through enhancing proliferation, suppressing apoptosis and inducing epithelial-mesenchymal transition.
    Gao Y; Ma H; Gao C; Lv Y; Chen X; Xu R; Sun M; Liu X; Lu X; Pei X; Li P
    J Transl Med; 2018 Feb; 16(1):38. PubMed ID: 29471858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-374c-5p regulates the invasion and migration of cervical cancer by acting on the Foxc1/snail pathway.
    Huang Y; Huang H; Li M; Zhang X; Liu Y; Wang Y
    Biomed Pharmacother; 2017 Oct; 94():1038-1047. PubMed ID: 28810526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-204-5p/Six1 feedback loop promotes epithelial-mesenchymal transition in breast cancer.
    Zeng J; Wei M; Shi R; Cai C; Liu X; Li T; Ma W
    Tumour Biol; 2016 Feb; 37(2):2729-35. PubMed ID: 26408179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.